A Decade of Olympus India's Commitment to Community Welfare Olympus Apr 22, 2025 12:00 HKT/SGT Read More
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce Hua Medicine Mar 18, 2025 22:36 HKT/SGT Read More
Olympus Announces Milestone for iTind(TM) Device with Expanded Availability Across Major APAC Markets Olympus Feb 26, 2025 10:00 HKT/SGT Read More
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives Eisai Feb 20, 2025 12:29 HKT/SGT Read More
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 China Medical System Holdings Ltd. Feb 14, 2025 21:00 JST Read More
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change Olympus Feb 10, 2025 10:00 HKT/SGT Read More
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 China Medical System Holdings Ltd. Jan 24, 2025 23:00 JST Read More
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company Eisai Jan 22, 2025 16:18 HKT/SGT Read More
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type China Medical System Holdings Ltd. Jan 09, 2025 09:00 JST Read More
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year Olympus Dec 24, 2024 10:00 HKT/SGT Read More
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia Eisai Dec 11, 2024 13:45 HKT/SGT Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China China Medical System Holdings Ltd. Dec 09, 2024 14:00 JST Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia China Medical System Holdings Ltd. Dec 02, 2024 22:30 JST Read More
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Eisai Nov 20, 2024 10:51 HKT/SGT Read More
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Eisai Nov 20, 2024 09:24 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus Nov 19, 2024 14:30 HKT/SGT Read More
